ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO062

State-Wide Coordination of the Follow-Up of Living Kidney Donors Only Marginally Improves the Follow-Up Rate

Session Information

Category: Transplantation

  • 1802 Transplantation: Clinical

Authors

  • Jose, Matthew D., Royal Hobart Hospital, Hobart, Tasmania, Australia
  • Cash, Ellie, University of Tasmania, Hobart, Tasmania, Australia
  • Brailsford, Gabrielle Elizabeth, University of Tasmania, Hobart, Tasmania, Australia
  • Kirkland, Geoff, Royal Hobart Hospital, Hobart, Tasmania, Australia
Background

Post-donation follow-up care is recommended by KDIGO for Living kidney donors (LKD). There is little long-term data on living kidney donors in Australia due to incomplete follow-up. In 2012 we centralised the follow-up of all LKD within the state. Our aim was to audit the effectiveness of this intervention and the effect on the rate of LKD follow-up.

Methods

In 2012 we reported follow-up of LKD at 1 year of 70%, but less than 10% at 5 years. Statewide follow-up was changed to be coordinated out of a single follow-up centre, with tests and appointments organized by standard mail and follow-up phone calls. We reviewed the effectiveness of this intervention.

Results

We identified 183 LKD, of which 126 (63% female, mean age 62 years, mean time since donation 9 years) were recorded in the both the statewide database and the Living Kidney Donor Registry (LKDR) at ANZDATA. Changing to a single, statewide follow-up centre achieved 50-70% of follow-up every year from 2014-17. This ranged from 75% at one year post-donation, 61% at 5 and 48% > 5 years post-donation as recorded locally in 2017. Reporting to the LKDR was lower at 25%, 33% & 22% respectively. From the ANZDATA follow up, 63 patients had a recorded systolic blood pressure measurement at their last follow up. 31% of these patients had hypertension requiring anti-hypertensive medication with 1.3 the average number of agents required.

Conclusion

The results show that clinical follow up decreases as time post donation increases. Statewide coordination of donor follow-up improved baseline results but there is still further improvement to be made. There is discrepancy between local data collection and submission to the Living Kidney Donor Registry at ANZDATA. Improved coordination and data submission would allow for more accurate follow up data of LKD.